Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 22, No 18 (September 15), 2004: pp. 3830-3832
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.10.199

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D. T.L.
Right arrow Articles by Lam, D. S.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D. T.L.
Right arrow Articles by Lam, D. S.C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

DIAGNOSIS IN ONCOLOGY

Challenging Problems in Malignancy

CASE 3. Chronic Lymphocytic Leukemia With Ocular Complications and Superior Vena Cava Obstruction

David T.L. Liu, Dorothy S.P. Fan, Wai-Man Chan, Paul C.L. Choi, Lei Gao, Dennis S.C. Lam

Department of Ophthalmology and Visual Sciences, Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong, People's Republic of China

A 69-year-old Chinese woman presented initially in March 2000 with bilateral cervical lymphadenopathy. Excisional lymph nodes biopsy showed diffuse infiltration by small lymphoid cells with scanty cytoplasm, round nuclei, and small single nucleoli, admixed with a few medium-sized prolymphocytes effacing the normal follicular architecture (Fig 1A). Immunophenotypic studies of the lymphoid cells revealed B-cell population expressing CD5 and CD23 (Figs 1B and 1C), together with the positive L26 (CD20) immunostain, confirming chronic lymphocytic leukemia (CLL) of B-cell lineage. She refused chemotherapy and did not return to the clinic after that. Two years later, she came back with diplopia, headache, and proptosis in both eyes. General inspection revealed that she was cachexic with congested superficial facial veins extending to the neck and supraclavicular region. Marked bitemporal soft tissue fullness and exophthalmos were apparent. Multiple cervical lymph nodes were palpable. Visual acuity of both eyes was 20/30 but gross restriction of extraocular motility was present, leading to binocular diplopia in all directions of the patient's gaze. Ophthalmoscopy revealed bilateral optic disc swelling, peripapillary retinal hemorrhage, and preretinal hemorrhage (Figs 2A and 2B). Computed tomography of brain and orbit demonstrated extensive tumor infiltrations over face with mass extending into both orbits (Fig 2C; bilateral enlarged lacrimal glands, white arrow; optic discs infiltration, black arrow; intraconal infiltrative mass of the left orbit, dotted arrow). In view of the possibility of superior vena cava obstruction, computed tomography of the thorax was performed and marked mediastinal lymphadenopathy (Fig 3; dotted arrow) resulting in superior vena cava and internal jugular vein compression (Fig 3; solid arrow) were noted. Hematologic investigation showed white cell counts 104,000/µL with 85% lymphocytosis (89,400/µL), hemoglobin 10.4 g/dL, RBCs 3,410/µL, and platelet count of 163,000/µL. Flow cytometry of peripheral blood confirmed CD19+, CD20+, CD22 weakly +, and surface immunoglubulin M+ with co-expression of CD5 and CD23. She had CLL of Binet stage B disease and an indolent disease with ocular complications and superior vena cava obstruction.1,2 The patient refused bone marrow aspiration or trephine biopsy and therapy of any form.



View larger version (176K):
[in this window]
[in a new window]
 
Fig 1.
 


View larger version (82K):
[in this window]
[in a new window]
 
Fig 2.
 


View larger version (102K):
[in this window]
[in a new window]
 
Fig 3.
 
Ocular involvement in leukemia can be caused by direct leukemic infiltration (3%) or indirectly due to the effects of low hematocrit, anemia, thrombocytopenia, hyperviscosity, or compromised immune status (39%), as reported in a prospective series of 120 patients.3 Ocular manifestations can precede the diagnosis of leukemia, occur during the course of the disease, or be a sequel to treatment.4,5 CLL is the most common leukemia in Western countries, but its ocular involvement is uncommon. Most of the previously published reports on ocular involvement have been biased towards acute leukemia, and a recent prospective study on 25 patients with CLL revealed no direct ocular infiltration.6

Authors' Disclosures of Potential Conflicts of Interest

The authors indicated no potential conflicts of interest.

REFERENCES

1. Binet R, Auquier Dighiero G, et al: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206, 1981[CrossRef][Medline]

2. Caligaris-Cappio F, Hamblin TJ: B-cell chronic lymphocytic leukemia: A bird of a different feather. J Clin Oncol 17:399-408, 1999[Abstract/Free Full Text]

3. Schachat AP, Markowitz JA, Guyer DR, et al: Ophthalmic manifestations of leukemia. Arch Ophthalmol 107:697-700, 1989[Abstract/Free Full Text]

4. Hatton MP, Rubin PAD, Mass B: Chronic lymphocytic leukemia of the orbit. Arch Ophthalmol 120:990-991, 2002[Free Full Text]

5. Schmid-Wendtner MH, Sander C, Volkenandt M, et al: Unusual manifestations of B-cell disorders. Case 2: chronic lymphocytic leukemia presenting with cutaneous lesions. J Clin Oncol 17:1084-1085, 1999

6. Buchan J, McKibbin M, Burton T: The prevalence of ocular disease in chronic lymphocytic leukemia. Eye 17:27-30, 2003[Medline]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D. T.L.
Right arrow Articles by Lam, D. S.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D. T.L.
Right arrow Articles by Lam, D. S.C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online